Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
about
Hormonal therapy in advanced or recurrent endometrial cancerAdjuvant chemotherapy for endometrial cancer after hysterectomyAvoidable mortality across Canada from 1975 to 1999Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancerKnockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B
P2860
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
type
label
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
prefLabel
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en-gb
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@nl
P2093
P2860
P1476
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
@en
P2093
P2860
P304
P356
10.1002/14651858.CD003915.PUB2
P577
2005-07-20T00:00:00Z